Beconase Aq

Cellulitis, Asthma, Nasal Polyps + 10 more
Treatment
20 Active Studies for Beconase Aq

What is Beconase Aq

Beclomethasone dipropionateThe Generic name of this drug
Treatment SummaryBeclomethasone dipropionate is an anti-inflammatory medication used to treat conditions like asthma, allergic rhinitis, and dermatoses. It comes in the form of an inhaler, dry powder inhaler, or an aqueous nasal spray. Beclomethasone dipropionate works by targeting the glucocorticoid receptor, reducing inflammation and providing relief from symptoms. Compared to earlier corticosteroids, beclomethasone dipropionate has a longer-lasting effect and is less irritating to the nasal mucosa.
Beconase AQis the brand name
image of different drug pills on a surface
Beconase Aq Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Beconase AQ
Beclomethasone dipropionate
1989
29

Effectiveness

How Beconase Aq Affects PatientsBeclomethasone dipropionate is a drug used to treat asthma, allergies, and skin conditions. When taken, it reduces inflammation and improves lung function. It is mainly inhaled, but long-term use can lead to decreased hormone production and bone issues. It may also increase the risk of infections due to the suppression of the immune system. Inhaling beclomethasone dipropionate can cause a fungal infection in the mouth and throat.
How Beconase Aq works in the bodyBeclomethasone dipropionate is a corticosteroid that works to reduce inflammation. After being activated, it binds to glucocorticoid receptors in the nucleus which then bind to genes that reduce inflammation. Corticosteroids also work by increasing the transcription of genes that code for anti-inflammatory proteins, and by inhibiting the expression of genes that code for pro-inflammatory proteins. This helps to reduce chronic inflammation by preventing the activity of inflammatory transcription factors and promoting histone deacetylation, which keeps DNA tightly coiled.

When to interrupt dosage

The proposed measure of Beconase Aq is dependent upon the diagnosed malady, such as Adrenal Cortex Hormones, Dermatosis and Nasal Polyps. The quantity of dosage relies upon the technique of application (e.g. Aerosol, metered; Suspension - Nasal or Powder - Respiratory (inhalation)) noted in the table beneath.
Condition
Dosage
Administration
Cellulitis
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Asthma
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Nasal Polyps
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Nasal Polyps
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Operation on nose
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Dermatosis
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Skin Diseases
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
corticosteroid responsive
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Hay Fever
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Sinusitis
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Rhinitis, Allergic
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Sinusitis
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)
Rhinitis, Vasomotor
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Aerosol, metered - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered, Suspension, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation)

Warnings

Beconase Aq has six contra-indications and should not be consumed with any of the conditions listed in the accompanying table.Beconase Aq Contraindications
Condition
Risk Level
Notes
Cellulitis
Do Not Combine
Tuberculosis
Do Not Combine
Status Asthmaticus
Do Not Combine
infected skin lesions
Do Not Combine
Virus Diseases
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Beclomethasone Dipropionate may interact with Pulse Frequency
There are 20 known major drug interactions with Beconase Aq.
Common Beconase Aq Drug Interactions
Drug Name
Risk Level
Description
2-Methoxyethanol
Major
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin A
Major
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Abatacept
Major
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Abatacept.
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Beclomethasone dipropionate.
Abetimus
Major
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Abetimus.
Beconase Aq Toxicity & Overdose RiskThe toxic dose of beclometasone dipropionate for rats is greater than 3750mg/kg. Inhaling large amounts of this drug over a short period of time can cause problems with the HPA axis. Long-term use of this drug may lead to adrenal suppression.
image of a doctor in a lab doing drug, clinical research

Beconase Aq Novel Uses: Which Conditions Have a Clinical Trial Featuring Beconase Aq?

Condition
Clinical Trials
Trial Phases
Asthma
92 Actively Recruiting
Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3
Skin Diseases
0 Actively Recruiting
Nasal Polyps
4 Actively Recruiting
Phase 2, Phase 3, Phase 4
corticosteroid responsive
0 Actively Recruiting
Hay Fever
0 Actively Recruiting
Sinusitis
0 Actively Recruiting
Cellulitis
0 Actively Recruiting
Rhinitis, Allergic
0 Actively Recruiting
Operation on nose
0 Actively Recruiting
Dermatosis
0 Actively Recruiting
Rhinitis, Vasomotor
0 Actively Recruiting
Sinusitis
5 Actively Recruiting
Early Phase 1, Phase 2, Phase 3, Phase 1
Nasal Polyps
0 Actively Recruiting

Beconase Aq Reviews: What are patients saying about Beconase Aq?

5Patient Review
4/12/2010
Beconase Aq for Inflammation of the Nose due to an Allergy
I had hay fever for 25 years and tried a bunch of different oral medications with no luck. Finally, a chemist recommended Beconase to me and it was an absolute lifesaver. I don't suffer from hay fever anymore, and I didn't experience any negative side effects that I'm aware of.
5Patient Review
9/27/2016
Beconase Aq for Inflammation of the Nose
I've been using this nasal spray for over 25 years and it's the only one that really works for me. No side effects that I can tell, which is amazing.
5Patient Review
9/5/2008
Beconase Aq for Inflammation of the Nose due to an Allergy
My husband has dealt with hay fever his entire life, but this medication has given him two symptom-free seasons. He's really happy about it!
5Patient Review
12/18/2008
Beconase Aq for Inflammation of the Nose due to an Allergy
Beconase AQ has really helped me a lot. I'm finally able to live without worrying about my sinuses all the time.
5Patient Review
3/4/2011
Beconase Aq for Inflammation of the Nose due to an Allergy
This medication has been incredible for me in managing my migraines. It's the only thing that works for me, and I've had no adverse effects from using it as directed.
3Patient Review
6/9/2009
Beconase Aq for Inflammation of the Nose
After using this spray for two weeks, I gained eight pounds. Most of the weight was in my stomach area and I also experienced flatulent distension. It's been three months since I stopped using the spray and the weight hasn't gone down yet. This is the heaviest I've ever been.
2Patient Review
3/18/2022
Beconase Aq for Inflammation of the Nose due to an Allergy
This brand is a subpar and irritating product that made my asthma worse, not better. I would be careful before using this brands' products.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about beconase aq

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the generic name for Beconase AQ?

"There is not currently a generic form of Beconase AQ (beclomethasone), so it can be expensive, even with insurance."

Answered by AI

What is Beconase AQ used for?

"Beclomethasone prevents and treats seasonal and year-round allergy symptoms by reducing inflammation. It is often used to treat symptoms caused by other triggers, such as cigarette smoke or perfumes."

Answered by AI

Is Beconase AQ a steroid?

"Beconase AQ is a steroid that is used to treat different nasal symptoms such as congestion, sneezing and a runny nose. This is often caused by seasonal allergies or allergies that occur all year round. Beconase AQ is also used to prevent nasal polyps from returning after surgery to remove them."

Answered by AI

Is Beconase AQ over the counter?

"Relieves nasal allergy symptoms . Beconase AQ (beclomethasone) is a strong steroidal nasal spray that is available over the counter without a prescription. It is very effective at relieving nasal allergy symptoms, but is only available as brand so it may be expensive."

Answered by AI

Clinical Trials for Beconase Aq

Have you considered Beconase Aq clinical trials? We made a collection of clinical trials featuring Beconase Aq, we think they might fit your search criteria.Go to Trials
Image of Allergy Immunology Associates in Mayfield Heights, United States.

Osteopathic Manipulative Treatment for Asthma

18 - 60
All Sexes
Mayfield Heights, OH
Asthma is a common respiratory condition that can be difficult to control despite the use of medications such as inhalers, oral steroids or even injectable medications. Osteopathic Manipulative Treatment (OMT) is a hands-on technique used to improve the chest structure and function and may help in improving breathing. Previous research showed that OMT in asthma patients, can improve the movement of the ribs and improve the "peak flow" which is the maximum rate at which a person can exhale air after taking a deep breath. However, no studies have evaluated the impact of OMT on lung inflammation. This single-site research study at University Hospitals aims to evaluate whether Osteopathic Manipulative Treatment (OMT) can reduce lung inflammation and improve breathing and lung function in adult patients with asthma. The lung function will be evaluated by Spirometry which is a test that measures how much air you can breathe in and out of your lungs, as well as how quickly and easily you can exhale air. The lung inflammation will be measured using a device that can detect how much you are breathing out Nitric Oxide which is a gas produced by inflamed cells in the lungs, this test is called: Fractional exhaled Nitric Oxide or FeNO. Approximately 100 participants will be enrolled.
Waitlist Available
Has No Placebo
Allergy Immunology AssociatesNancy Wasserbauer-Kingston, DO
Image of DARTNet Institute in Aurora, United States.

Inhaled Corticosteroids + Azithromycin for Asthma

13 - 75
All Sexes
Aurora, CO
While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long term side effects. This study will compare two currently available approaches to reduce AEX in primary care patients: (1) use of inhaled corticosteroids (ICS) as part of rescue therapy, also known as MART (Maintenance And Reliever Therapy) or PARTICS (Patient Activated Reliever Trigger Inhaled Corticosteriods) therapy - either of these therapies will be called Rescue-Inhaled Corticosteroids or R-ICS pronounced "Ricks," and (2) use of azithromycin (AZ) as a preventive therapy. These treatments will be studied both individually and in combination.
Phase 4
Recruiting
DARTNet Institute (+12 Sites)Wilson D Pace, MD, FAAFP
Image of Medical Place Pharmacy in Ajax, Canada.

Pharmacy Support System for Asthma

Any Age
All Sexes
Ajax, Canada
The goal of this study is to assess the effect of an electronic asthma management system in pharmacies (eAMS-Pharm) on asthma control assessment, asthma medication adjustment, asthma action plan delivery, and prompting for specialist referral in severe asthma. The study assesses the differences on pharmacy processes (affecting both the pharmacy team and patients) and pharmacy-delivered care using an interrupted time-series analysis (six-months before vs. six-months after the introduction of eAMS-Pharm in study pharmacy sites). The eAMS-Pharm uses patient data (asthma control, asthma flare-up risk, and current medications) to provide clinical decision support to pharmacists, empowering them to bridge existing gaps between guideline-recommended asthma care and patient care received.
Waitlist Available
Has No Placebo
Medical Place Pharmacy (+2 Sites)
Image of St. Paul's Hospital in Vancouver, Canada.

Salbutamol for Athletic Performance

18 - 55
All Sexes
Vancouver, Canada
β2-Agonists, commonly used to treat asthma, have also been used by athletes to enhance performance, leading to their ban by the International Olympic Committee in 1972. Research has shown non-asthmatics receive no benefit from these drugs at therapeutic dosages; however, many elite athletes still use them, and asthmatic athletes often win more Olympic medals. In some non-asthmatics, β2-agonists may improve breathing limitations during high intensity exercise, which may improve performance. Therefore, we aim to examine if there is a select group of non-asthmatic individuals who experience breathing limitations that may receive benefit from β2-agonists.
Waitlist Available
Paid Trial
St. Paul's HospitalJordan A Guenette, PhD
Have you considered Beconase Aq clinical trials? We made a collection of clinical trials featuring Beconase Aq, we think they might fit your search criteria.Go to Trials
Image of Velocity Clinical Research, Mobile in Mobile, United States.

PF-07275315 for Asthma

18 - 70
All Sexes
Mobile, AL
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning of people who are affected. This study is seeking participants who: * Are 18 to 70 years old * Have had moderate-to-severe asthma for at least 12 months that is not well controlled * Have been taking their regular maintenance treatment(s) for asthma over the last 12 months All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 12 weeks. We will compare the experiences of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective. Participants will be involved in this study for about 9.5 months. During this time, they will have 10 visits at the study clinic.
Phase 2
Recruiting
Velocity Clinical Research, Mobile (+10 Sites)Pfizer CT.gov Call CenterPfizer
Image of St. Joseph's Healthcare Hamilton in Hamilton, Canada.

Corticosteroids for Asthma

18+
All Sexes
Hamilton, Canada
Most individuals with asthma can effectively manage their symptoms and maintain normal lung function using inhaled medications, unfortunately, there is a subset of asthma sufferers whose symptoms, lung function, and risk of asthma attacks remain unimproved despite conventional inhaled medications. There could be several reasons for this. One possibility is that inhaled medications fail to reach the intended areas within the lungs, due to structural abnormalities within the airways themselves. Much like road conditions or closures can impede the speed and efficiency of vehicle travel, factors such as airway narrowing or mucus blockages, which are common in asthma, can obstruct the passage of inhaled medications through the airways. Our team has now optimized advanced medical imaging techniques, including magnetic resonance imaging (MRI) and computed tomography (CT), required to investigate this. This study will use these imaging methods to visually assess and measure individual patients' airways and determine whether abnormal airway structures impact how well they respond to inhaled and orally delivered medications. We anticipate finding that abnormal airway structures make inhaled medications less effective, but that they do not affect the response to oral medications.
Phase 4
Recruiting
St. Joseph's Healthcare Hamilton (+1 Sites)
Have you considered Beconase Aq clinical trials? We made a collection of clinical trials featuring Beconase Aq, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security